Showing results (91-100 of 194) with videos related to

Sort By:
Pageof 20
Bone Marrow Transplantation|April 13, 2021
Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantationJin Wu, Hai-Xia Fu, Yun He, et al.
Bone Marrow Transplantation|March 24, 2019
Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantationZheng-Li Xu, Lan-Ping Xu, Yuan-Yuan Zhang, et al.
Frontiers in Cellular and Infection Microbiology|April 8, 2022
A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell TransplantationMeng-Zhu Shen, Shen-Da Hong, Jie Wang, et al.
British Journal of Haematology|November 15, 2018
Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: incidence and clinical courseFei-Fei Tang, Xiao-Dong Mo, Yu Wang, et al.
Oncoimmunology|February 10, 2017
Lower incidence of acute GVHD is associated with the rapid recovery of CD4+CD25+CD45RA+ regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) cohort-based studyYu Wang, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Medcomm|January 19, 2026
Low Dose of IL-2 Application for Graft-Versus-Host Disease Prophylaxis Following Haploidentical Stem Cell TransplantationZheng-Li Xu, Meng Lv, Xing-Xing Yu, et al.
Haematologica|October 12, 2023
Targeting TFH cells is a novel approach for donor-specific antibody desensitization of allograft candidates: an in vitro and in vivo studyNing Ma, Wei-Bing Wu, Xiang-Yu Zhao, et al.
European Journal of Haematology|January 28, 2017
Viral encephalitis after haplo-identical hematopoietic stem cell transplantation: Causative viral spectrum, characteristics, and risk factorsXiao-Hui Zhang, Jia-Min Zhang, Wei Han, et al.
Annals of Hematology|January 15, 2025
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemiaJun Kong, Feng-Mei Zheng, Chen-Hua Yan, et al.
Cancer Communications (London, England)|October 24, 2022
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessmentChen-Hua Yan, Yu Wang, Yu-Qian Sun, et al.
Pageof 20